Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer.
Saved in:
| Title: | Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer. |
|---|---|
| Authors: | Ji Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA., Huth F; Novartis Pharma AG, CH 4056 Basel, Switzerland., Wang C; Novartis Pharma AG, CH 4056 Basel, Switzerland., Schiller H; Novartis Pharma AG, CH 4056 Basel, Switzerland., Combes FP; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA., Crown J; Department of Medical Oncology, St Vincent's University Hospital, D04 T6F4 Dublin, Ireland., Fasching PA; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, 91054 Erlangen, Germany., Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA., Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, 13125 Berlin, Germany. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2026 Mar 11; Vol. 19 (3). Date of Electronic Publication: 2026 Mar 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1424-8247 |
|---|---|
| DOI: | 10.3390/ph19030461 |
